Skip to main content

Kalia Kumud's Form 4 filing

Guardant Health, Inc. (GH) · filed Nov 17, 2022

Accession no.
0001576280-22-000106
Filed
Nov 17, 2022
Trade date
Nov 15, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction. Open-market sales total $162.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kalia KumudCIK 0001927831Officer (Chief Information Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 15, 2022COMMON STOCKSSaleDisposed−3,125$51.87F1−$162,093.7520,135Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted average price of shares sold at prices that ranged from $51.8535 to $51.95.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)